FDA Approves GLP-1 pill, Foundayo, for Weight Loss

Health & LifestyleNews
265

Listen to article (english)

Translate to Spanish or other 102 languages!

The Food and Drug Administration (FDA) has approved Eli Lilly’s once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity, or overweight with weight-related medical problem. Image for illustration purposes
The Food and Drug Administration (FDA) has approved Eli Lilly’s once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity, or overweight with weight-related medical problem. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

The Food and Drug Administration (FDA) has approved Eli Lilly’s once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity, or overweight with weight-related medical problems.

This approval makes Eli Lilly’s oral GLP-1 receptor agonist, to be marketed as Foundayo, the second GLP-1 drug available in pill form, after Wegovy, which gained approval in December 2025.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/fda-approves-oral-glp-1-pill-foundayo-for-weight-loss

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Texas AG Opens New Medicaid Fraud Investigations Based on Newly Released Federal Data
Next article
Cold, Flu, or Allergies? Key Differences to Watch For

More Articles

Essential Strategies to Prevent Hot Car Tragedies

Mega Doctor News CLEVELAND CLINIC - With summer in full swing, experts say...

Physicians Flag Prediction Markets as a Rising Threat to Adolescents with Addiction Disorders

With online betting sites called prediction market platforms growing in popularity, the Texas Medical Association (TMA) is calling for increased regulations and safeguards to protect adolescents. 

VIDA Secures $300,000 to Boost Evidence-Based Mental Health Support for Students

Valley Initiative for Development and Advancement (VIDA) has been awarded a $300,000, two-year grant from Methodist Healthcare Ministries of South Texas, Inc. to launch an innovative initiative that integrates evidence-based mental health support into workforce development, strengthening student persistence and expanding access to care for underserved communities across the Rio Grande Valley.

How to Grill Lighter and Smarter This Fourth of July

Celebrating Independence Day with an old-fashioned cookout is as American as apple pie. Unfortunately, the traditional July Fourth menu wasn’t cooked up with nutrition as a priority.
- Advertisement -